Steven L. Gonias
Affiliations: | Molecular Pathology | University of California, San Diego, La Jolla, CA |
Area:
Neuroscience BiologyGoogle:
"Steven Gonias"Mean distance: 35622
Children
Sign in to add trainee| Simone Codeluppi | grad student | 2008 | UCSD |
| Boryana M. Eastman | grad student | 2012 | UCSD |
| Karra A Jones | post-doc | 2012-2014 |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Gunner CB, Azmoon P, Mantuano E, et al. (2023) An antibody that targets cell-surface glucose-regulated protein-78 inhibits expression of inflammatory cytokines and plasminogen activator inhibitors by macrophages. Journal of Cellular Biochemistry |
| Mantuano E, Azmoon P, Banki MA, et al. (2022) The LRP1/CD91 ligands, tissue-type plasminogen activator, α-macroglobulin, and soluble cellular prion protein have distinct co-receptor requirements for activation of cell-signaling. Scientific Reports. 12: 17594 |
| Sadri M, Hirosawa N, Le J, et al. (2021) Tumor necrosis factor receptor-1 is selectively sequestered into Schwann cell extracellular vesicles where it functions as a TNFα decoy. Glia |
| Gonias SL. (2021) Plasminogen activator receptor assemblies in cell-signaling, innate immunity, and inflammation. American Journal of Physiology. Cell Physiology |
| Mantuano E, Azmoon P, Banki MA, et al. (2020) A soluble derivative of PrP activates cell-signaling and regulates cell physiology through LRP1 and the NMDA Receptor. The Journal of Biological Chemistry |
| Shiga Y, Shiga A, Mesci P, et al. (2019) Tissue-type plasminogen activator-primed human iPSC-derived neural progenitor cells promote motor recovery after severe spinal cord injury. Scientific Reports. 9: 19291 |
| Pontecorvi P, Banki MA, Zampieri C, et al. (2019) Fibrinolysis protease receptors promote activation of astrocytes to express pro-inflammatory cytokines. Journal of Neuroinflammation. 16: 257 |
| Gonias SL, Zampieri C. (2019) Plasminogen Receptors in Human Malignancies: Effects on Prognosis and Feasibility as Targets for Drug Development. Current Drug Targets |
| Das L, Azmoon P, Banki MA, et al. (2019) Tissue-type plasminogen activator selectively inhibits multiple toll-like receptors in CSF-1-differentiated macrophages. Plos One. 14: e0224738 |
| Brifault C, Kwon H, Campana WM, et al. (2019) LRP1 deficiency in microglia blocks neuro-inflammation in the spinal dorsal horn and neuropathic pain processing. Glia |